DK1065209T3 - Metalproteaseinhibitorer, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse - Google Patents

Metalproteaseinhibitorer, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse

Info

Publication number
DK1065209T3
DK1065209T3 DK00401864T DK00401864T DK1065209T3 DK 1065209 T3 DK1065209 T3 DK 1065209T3 DK 00401864 T DK00401864 T DK 00401864T DK 00401864 T DK00401864 T DK 00401864T DK 1065209 T3 DK1065209 T3 DK 1065209T3
Authority
DK
Denmark
Prior art keywords
preparation
compositions containing
processes
pharmaceutical compositions
protease inhibitors
Prior art date
Application number
DK00401864T
Other languages
Danish (da)
English (en)
Inventor
Nanteuil Guillaume De
Alain Benoist
Jacqueline Bonnet
Massimo Sabatini
Ghanem Atassi
Alain Pierre
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of DK1065209T3 publication Critical patent/DK1065209T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
DK00401864T 1999-07-01 2000-06-30 Metalproteaseinhibitorer, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse DK1065209T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9908448A FR2795730B1 (fr) 1999-07-01 1999-07-01 Nouveaux inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
DK1065209T3 true DK1065209T3 (da) 2003-08-25

Family

ID=9547562

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00401864T DK1065209T3 (da) 1999-07-01 2000-06-30 Metalproteaseinhibitorer, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse

Country Status (22)

Country Link
US (1) US6339092B1 (de)
EP (1) EP1065209B1 (de)
JP (1) JP3330583B2 (de)
KR (1) KR100472521B1 (de)
CN (1) CN1147492C (de)
AT (1) ATE239021T1 (de)
AU (1) AU770168B2 (de)
BR (1) BR0002265A (de)
CA (1) CA2313302C (de)
DE (1) DE60002395T2 (de)
DK (1) DK1065209T3 (de)
EA (1) EA002527B1 (de)
ES (1) ES2198262T3 (de)
FR (1) FR2795730B1 (de)
HK (1) HK1034968A1 (de)
HU (1) HUP0002554A3 (de)
NO (1) NO20003431L (de)
NZ (1) NZ505522A (de)
PL (1) PL341134A1 (de)
PT (1) PT1065209E (de)
SI (1) SI1065209T1 (de)
ZA (1) ZA200003310B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002324716A1 (en) * 2001-08-17 2003-03-03 Bristol-Myers Squibb Company Patent Department Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or tnf-$g(a) converting enzyme (tace)
DE102005002500A1 (de) * 2005-01-19 2006-07-27 Sanofi-Aventis Deutschland Gmbh Tetrahydrofuranderivate als Inhibitoren von Matrix-Metalloproteinasen
US20110034526A1 (en) * 2007-12-21 2011-02-10 Wyeth Llc Benzimidazole Compounds
KR100962022B1 (ko) 2010-01-12 2010-06-08 (주) 유니크코리아엔아이 정전용량형 압력센서 및 그 제조방법
RU2655727C9 (ru) * 2013-03-14 2018-07-06 ГлаксоСмитКлайн Интеллекчуал Проперти (N2) Лимитед Фуропиридины в качестве ингибиторов бромодоменов

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2748026B1 (fr) * 1996-04-26 1998-06-05 Adir Nouveaux inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE19719817A1 (de) * 1997-05-13 1998-11-19 Hoechst Ag Substituierte 6- und 7-Aminotetrahydroisochinolincarbonsäuren
EP1003751A1 (de) * 1997-08-04 2000-05-31 Amgen Inc. Hydroxamsäure substituierte kondensierte heterocyclische metalloproteinase inhibitoren

Also Published As

Publication number Publication date
EP1065209A1 (de) 2001-01-03
KR100472521B1 (ko) 2005-03-08
HK1034968A1 (en) 2001-11-09
HUP0002554A2 (hu) 2002-04-29
ZA200003310B (en) 2001-01-25
SI1065209T1 (en) 2003-08-31
AU770168B2 (en) 2004-02-12
CA2313302A1 (fr) 2001-01-01
US6339092B1 (en) 2002-01-15
NO20003431D0 (no) 2000-06-30
CA2313302C (fr) 2004-06-15
EP1065209B1 (de) 2003-05-02
HUP0002554A3 (en) 2002-12-28
AU4378400A (en) 2001-01-04
EA002527B1 (ru) 2002-06-27
NZ505522A (en) 2001-12-21
FR2795730B1 (fr) 2001-08-31
EA200000598A1 (ru) 2001-02-26
DE60002395T2 (de) 2004-04-08
CN1290703A (zh) 2001-04-11
JP2001039983A (ja) 2001-02-13
NO20003431L (no) 2001-01-02
PL341134A1 (en) 2001-01-02
PT1065209E (pt) 2003-08-29
JP3330583B2 (ja) 2002-09-30
CN1147492C (zh) 2004-04-28
DE60002395D1 (de) 2003-06-05
ATE239021T1 (de) 2003-05-15
HU0002554D0 (en) 2000-08-28
FR2795730A1 (fr) 2001-01-05
BR0002265A (pt) 2001-03-13
KR20010039689A (ko) 2001-05-15
ES2198262T3 (es) 2004-02-01

Similar Documents

Publication Publication Date Title
BRPI0506817A (pt) inibidores seletivos de quinase
EP1371650A4 (de) Aktivator für peroxisom-proliferator-aktivierte rezeptoren
ATE512962T1 (de) Pyrazolo 1,5-a pyridine und diese enthaltende arzneimittel
HRP20080668T3 (en) Matrix metalloproteinase inhibitors
EA200300927A1 (ru) Новый способ промышленного синтеза тетрасложных эфиров 5-[бис(карбоксиметил)амино]-3-карбоксиметил-4-циано-2-тиофенкарбоновой кислоты и применение для синтеза бивалентных солей ранелиновой кислоты и их гидратов
AU8811401A (en) Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient
DK1065209T3 (da) Metalproteaseinhibitorer, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
DE69824450D1 (de) Biphenylamidin-derivate
DK0937043T3 (da) Substituerede tetrahydropyridin-derivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse derivater
DK1042326T3 (da) Nye acronycinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger, som indeholder disse
CY1110898T1 (el) Νεα παραγωγα πυριδινοκαρβοξυλικου οξεος ή αλατα αυτων
ATE401884T1 (de) Arzneizusammensetzungen enthaltend oxapenem-3- carbonsäuren
BR0101466A (pt) Compostos de ciclobutaindolcarboxamida,processo para a sua preparação e composiçõesfarmacêuticas contendo os mesmos
EA200300009A1 (ru) Производные 4,5-дигидротиазол-2-иламина и их применение в качестве ингибиторов no синтазы
AR046233A1 (es) Derivados de piperidinillactamas, procedimiento para prepararlos y composicion farmaceutica.